Back to TB Tweedy, Browne Co LLC

VRTX

Showing 9 of 13 quarters

Position history for TBTweedy, Browne Co LLC's holdings in Vertex Pharmaceuticals Incorporated

Yes. Tweedy, Browne holds 26,013 shares of VRTX (Vertex Pharmaceuticals), worth $13.6M, as of its Q3 2026 13F filing. It reduced the position by 14,108 shares (-35.2%) from Q2 2026. Tweedy, Browne has held VRTX since Q3 2023, across 13 quarterly 13F filings. VRTX is 1.1% of Tweedy, Browne's reported 13F portfolio.

Current Value

$13.6M

Current Shares

26,013

Total Value Change

-$11.3M

Total Shares Change

-27,587

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
26,013
-35.2%
$13.6M1.1%$522.81
0
2026-Q2
Decreased
40,121
-0.7%
$19.9M1.5%$496.73
0
2026-Q1
Increased
40,387
+3.2%
$18M1.4%$446.54
46
2025-Q4
Increased
39,148
+0.2%
$17.7M1.4%$453.36
44
2025-Q3
Increased
39,065
+4.9%
$15.3M1.3%$391.64
47
2025-Q2
Decreased
37,253
-2.8%
$16.6M1.5%$445.20
0
2025-Q1
Decreased
38,316
-5.7%
$18.6M1.6%$484.82
0
2024-Q4
Decreased
40,631
-24.2%
$16.4M1.1%$402.70
0
2024-Q3
Decreased
53,600
-1.4%
$24.9M1.2%$465.08
0

Other major holders of VRTX: Capital World Investors

Optional analytics helps us improve. How it’s used